[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:chromosomal-translocation":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Chromosomal Translocation",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03866382","Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors",[11],"Phase 2","RECRUITING","2026-08-26T02:19:24.527214Z","2026-05-05T02:43:29.038812Z"]